Mather Group, Llc. Pfizer Inc Transaction History

Mather Group, Llc.

$9.81 Billion
Q3 2025

A detailed history of Mather Group, Llc. transactions in Pfizer Inc stock. As of the latest transaction made, Mather Group, Llc. holds 12,409 shares of PFE stock, worth $307,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,409

Previous 11,668 6.35%

Holding current value

$307,370

Previous $282,000 12.06%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	BUY	$23.29 - $25.88 $17,257 - $19,177	741 Added 6.35%	12,409 $316,000
Q2 2025 Jul 15, 2025	SELL	$21.59 - $24.84 $227,062 - $261,242	-10,517 Reduced 47.41%	11,668 $282,000
Q1 2025 Apr 25, 2025	BUY	$25.01 - $27.13 $49,469 - $53,663	1,978 Added 9.79%	22,185 $562,000
Q4 2024 Jan 24, 2025	SELL	$24.8 - $30.19 $114,129 - $138,934	-4,602 Reduced 18.55%	20,207 $536,000
Q3 2024 Oct 07, 2024	SELL	$27.7 - $31.39 $712,831 - $807,790	-25,734 Reduced 50.92%	24,809 $717,000
Q2 2024 Jul 08, 2024	BUY	$25.26 - $29.6 $605,962 - $710,074	23,989 Added 90.34%	50,543 $1.41 Million
Q1 2024 Apr 08, 2024	SELL	$25.89 - $29.73 $30,524 - $35,051	-1,179 Reduced 4.25%	26,554 $736,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $168,172 - $218,437	-6,436 Reduced 18.84%	27,733 $798,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $284,221 - $332,226	8,857 Added 34.99%	34,169 $1.13 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $380,596 - $440,341	-10,537 Reduced 29.39%	25,312 $928,000
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $641,032 - $834,530	-16,274 Reduced 31.22%	35,849 $1.46 Million
Q4 2022 Mar 10, 2023	BUY	$41.75 - $54.5 $113,100 - $147,640	2,709 Added 5.48%	52,123 $2.67 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $332,619 - $406,045	7,601 Added 18.18%	49,414 $2.16 Million
Q2 2022 Aug 16, 2022	BUY	$46.53 - $55.17 $108,787 - $128,987	2,338 Added 5.92%	41,813 $2.19 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $819,382 - $1.02 Million	17,910 Added 83.05%	39,475 $2.04 Million
Q4 2021 Feb 15, 2022	BUY	$41.32 - $61.25 $284,075 - $421,093	6,875 Added 46.8%	21,565 $1.27 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $15,150 - $19,462	-386 Reduced 2.56%	14,690 $632,000
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $5,853 - $6,630	163 Added 1.09%	15,076 $590,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $22,672 - $25,570	-677 Reduced 4.34%	14,913 $540,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $2,142 - $2,723	-64 Reduced 0.41%	15,590 $574,000
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $32,416 - $38,032	-1,021 Reduced 6.12%	15,654 $574,000
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $502,251 - $609,304	16,675 New	16,675 $545,000

Others Institutions Holding PFE

# of Institutions

3,309

Shares Held

3.65B

Call Options Held

96.5M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account